Inhibrx Biosciences, Inc. 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-08 6:00 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
3,147,235 7.200% |
650,849 (+26.07%) |
Filing |
| 2023-03-08 6:00 pm Sale |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
2,496,386 5.700% |
-810,924 (-24.52%) |
Filing |
| 2023-03-08 5:59 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
3,307,310 7.600% |
995,855 (+43.08%) |
Filing |
| 2022-02-11 5:37 pm Sale |
2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
2,311,455 5.900% |
-1,098,669 (-32.22%) |
Filing |
| 2022-02-11 5:37 pm Purchase |
2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
3,410,124 8.700% |
683,338 (+25.06%) |
Filing |
| 2022-02-11 5:37 pm Sale |
2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
2,726,786 7.000% |
-462,199 (-14.49%) |
Filing |
| 2022-02-11 5:37 pm Purchase |
2021-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
Inhibrx Inc. INBX |
3,188,985 8.200% |
3,188,985 (New Position) |
Filing |